← Open Payments lookup

HERBERT ZINZOMBE: Open Payments

NPI 1164178075 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,323 in 119 payments from 14 companies in 2025. Trend: 2023 $1,694 · 2024 $1,191 · 2025 $2,323

Food & beverage: $2,213Education: $109
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.22$409
Otsuka America Pharmaceutical, Inc.21$334
Alkermes, Inc.12$310
Vanda Pharmaceuticals Inc.10$282
Supernus Pharmaceuticals, Inc.12$211
Teva Pharmaceuticals USA, Inc.6$177
E.R. Squibb & Sons, L.L.C.9$162
ABBVIE INC.10$144
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$136
Gilead Sciences, Inc.3$49

Products named: INGREZZA, REXULTI, Qelbree, HETLIOZ, ARISTADA, COBENFY, CAPLYTA, VRAYLAR.

Industry payments across IN — which companies pay providers there.